Healthtech & Wellness VC Funds

Scale Venture Partners is a leading venture capital firm that invests in early-stage technology companies, particularly those leveraging AI, SaaS, fintech, and security solutions. Based in Foster City, California, Scale typically leads Series A or B rounds, helping startups transition from founder-led growth to scalable, go-to-market machines. Their portfolio includes prominent companies like HubSpot, JFrog, and Papaya Global, which demonstrate their focus on transformative business software across various sectors. Scale Venture Partners takes an active role in its portfolio companies, often serving on boards and providing tailored support through its Scaling Platform, which offers access to executive networks, go-to-market strategies, and benchmarking tools. Their strategic focus on emerging technologies allows them to identify and nurture companies poised for category leadership in areas such as infrastructure, AI, and productivity. With over $2.8 billion in assets under management and a $900 million fund raised in 2022, Scale continues to back high-growth startups across North America, Europe, and Israel. They aim to support companies all the way to IPO, offering deep industry insights and operational expertise. Founders looking for strategic backing to scale their enterprises find a valuable partner in Scale Venture Partners.

ScaleX Ventures is an early-stage technology venture capital firm founded in 2017 and headquartered in Sisli, Istanbul, Turkey, with additional operating presence in the San Francisco Bay Area. The firm was co-founded by Dilek Dayinlarli, Managing Partner, and Berkay Mollamustafaoglu, best known as the co-founder of Opsgenie, which was acquired by Atlassian. The partnership's operator track record also includes early-stage involvement with Insider and COO experience at Peak Games. The 13-person team includes 3 Partners, 2 Venture Partners, and 1 Principal. ScaleX backs bold founders building category-defining technology companies from seed through Series A, with initial checks of roughly 300,000 euros to 3 million euros. The firm is sector-agnostic but concentrates in B2B SaaS, enterprise software, AI, cybersecurity, and software infrastructure. Geographically, the firm prioritises Central and Eastern Europe and Turkey alongside US founders of Turkish or CEE origin — with a stated mission to close the opportunity gap for founders in unusual places. Across Fund I, ScaleX made approximately 22 investments, with 2024 as its most active year at 7 new deals. Named portfolio companies include Ubicloud (open-source cloud infrastructure), KuzuDB (graph database), Meditopia, Flowla, Bluedot, Finch, Hilbert's AI, Periodic Labs, Figopara, and Buluttan. The most recent exit was Kondukto, acquired by Invicti. A signature innovation at ScaleX is the Founders' Partner Program: every portfolio founder receives a share of ScaleX's fund profits, embedding a mutual stake in outcomes across the entire portfolio. This structural alignment reflects the firm's founding belief that the best investors are themselves founder-caliber operators, and that venture capital works best when the incentives of managers and founders are genuinely shared.

SCI Ventures is a novel evergreen venture capital fund headquartered in London, United Kingdom, founded in 2023 and formally launched with capital in mid-2024. The fund's singular mission is to catalyse innovative cures and restorative treatments for spinal cord injury and paralysis. It was created as the first-ever collaboration between five leading spinal cord injury foundations across the US, UK, and European Union: the Christopher and Dana Reeve Foundation, Wings for Life, Spinal Research, Promobilia, and the Shepherd Center. SCI Ventures launched with approximately $27 million of initial commitments toward a $40 million target, and is advised by a network of world-class neuroscientists and clinicians. The fund was founded by Cohen — a tech entrepreneur who co-founded both Tractable and Lazada, both unicorns above $1 billion in value — after his brother was paralysed in an accident. The investment team is led by Cohen as Founder, supported by Investment Principal Roman Rothaermel and Senior Investment Associate Karen Chan. Every potential portfolio company is evaluated against three criteria: clinical impact on spinal cord injury patients, scientific maturity, and financial return potential. The fund deploys primarily into Series A and Series B rounds in healthcare, life sciences, and neurotechnology. Across 4 disclosed investments, named portfolio companies include Precision Neuroscience — a brain-computer interface company in which SCI Ventures announced a seven-figure investment and strategic partnership in November 2025, providing Precision with access to the firm's patient, physician, and regulatory network — and OrangeX, which raised a $20 million Series B in August 2025. SCI Ventures occupies a rare position as a fund that blends venture philanthropy with commercial investing: foundation anchors provide mission alignment and clinical network access, while commercial discipline ensures the portfolio is built for durable financial returns alongside patient impact.

Science Angel Syndicate, founded in 2021 and based in Bristol, UK, is an angel investment group focused on early-stage scientific startups. The syndicate brings together a community of entrepreneurs and investors dedicated to backing groundbreaking scientific discoveries that have the potential to make a significant societal impact. With a focus on disruptive technologies at the intersection of biology, chemistry, physics, and computer science, the group is particularly interested in companies that align with the emerging Industry 5.0, where human intelligence is enhanced by cognitive computing and automation. Science Angel Syndicate has made 15 investments across various sectors, including biotechnology, drug discovery, and healthcare devices, with companies like MitoRx Therapeutics and Neuronostics being part of their portfolio. The syndicate supports startups that aim to address critical challenges related to health and the environment, providing not only capital but also access to a network of experts across scientific and commercial domains. The syndicate's unique approach involves leveraging the collective knowledge and experience of its members to thoroughly assess the potential of frontier scientific companies. This collaborative method ensures that investments are made in technologies that are not only innovative but also commercially viable and scalable.

Science Creates is a Bristol-based deep tech ecosystem designed to support scientists and engineers in transforming their ideas into impactful businesses. Founded in partnership with the University of Bristol, Science Creates provides specialized incubator facilities, a network of strategic partners, and a dedicated venture capital fund to accelerate the growth of deep tech startups. The ecosystem comprises two state-of-the-art incubators in central Bristol, offering 45,000 square feet of laboratory, office, and event space. These facilities are specifically designed to cater to the unique needs of deep tech companies, particularly those in biotechnology, materials science, and other advanced technologies. The incubators support startups from the very early stages through to scaling up, providing access to crucial resources such as mentoring, specialized equipment, and industry connections. In addition to the physical infrastructure, Science Creates also manages Science Creates Ventures, a venture capital arm that invests in early-stage deep tech companies. The fund focuses on pre-seed to Series A investments, supporting innovations that have the potential to address significant global challenges in health, energy, and the environment.

SciFi VC is an early-stage venture capital firm founded by Max and Nellie Levchin, focusing on fintech, marketplaces, and scientific breakthroughs. The firm partners with founders who display intense curiosity and intellectual depth, addressing hard problems that often require innovative and science-driven solutions. SciFi VC supports startups from the brainstorming stage, helping define product and strategy before leading the seed round. They bring deep domain expertise and intellectual rigor to early-stage investments, offering strategic support through critical product, strategy, and fundraising decisions. Notable investments include Brex and Loft, with SciFi VC providing essential support in areas such as fundraising, partnerships, and operational advice. The firm also makes opportunistic investments in later-stage companies showing exceptional growth, ensuring long-term partnership and value creation. By emphasizing technology's role in creating next-generation financial products, digital marketplaces, and commercializing scientific advancements, SciFi VC aims to turn science fiction into reality and foster high-impact ventures.

SciFounders is a venture capital firm established in 2021 and based in San Francisco, California. The firm specializes in supporting early-stage, highly technical startups, particularly those operating in the biotech, diagnostics, drug delivery, and deep tech sectors. SciFounders is unique in its approach, focusing on the idea stage, pre-seed, and seed investments, which allows it to engage with companies at the earliest stages of their development. One of the standout features of SciFounders is its SciFounder Fellowship program. This mentorship initiative is designed to support idea-stage founders by providing them with up to $400,000 in investment, along with guidance from a network of experienced entrepreneurs and scientists who have a proven track record in building impactful technologies. The fellowship aims to help founders navigate the complex journey from scientific innovation to commercial success. The leadership team at SciFounders brings deep expertise from both the scientific and entrepreneurial worlds. Notable team members include Matt Krisiloff, previously the director of Y Combinator Research and a founding team member of OpenAI, and Lucas Harrington, co-founder of Mammoth Biosciences, a company known for its pioneering work in CRISPR technology. SciFounders is committed to empowering scientists and technical founders to bring their groundbreaking ideas to life, providing both the financial backing and the mentorship necessary to turn innovative concepts into successful companies.

ScOp Venture Capital, based in Santa Barbara, California, focuses on early-stage investments in software-as-a-service (SaaS) companies, with a strong emphasis on businesses that have moved past market validation and are now in the growth stage. The fund typically invests between $500,000 to $1 million, aiming for companies with $500,000 to $1 million in annual recurring revenue (ARR). ScOp Venture Capital primarily targets the fintech sector, with notable investments in startups like Pearly, a company that automates patient billing and revenue cycle management for dental groups. This focus on solving significant industry problems with innovative solutions is a hallmark of their investment strategy. ScOp prefers to partner with companies that have a clear market traction and a passionate founding team dedicated to making a substantial impact​. The firm is led by Kevin O'Connor, a seasoned entrepreneur with a track record of founding and scaling successful companies, including DoubleClick, which was acquired by Google. His extensive experience and hands-on approach provide valuable mentorship to portfolio companies, helping them navigate the challenges of scaling and market expansion​. For startups looking to secure investment from ScOp Venture Capital, demonstrating a strong product-market fit and a committed, driven team is crucial. The firm values simplicity and problem-solving over flashy technology, focusing on real-world applications that deliver significant value to customers​.

Scopus Ventures is a Los Angeles-based early-stage venture capital firm founded in 2016 and headquartered at 11859 Wilshire Boulevard, Suite 500. The firm was created by co-founders Bahram Nour-Omid, Eran Gilad, and Robert Mai — all seasoned entrepreneurs and investors — and operates with a team of approximately five including four Partners and one Venture Partner. Scopus's distinctive thesis centers on Israeli founders making the leap to the US market: the firm backs late-seed and early Series A companies that have shipped product and reached validated product-market fit, with a particular focus on enterprise software, automation-driven technologies, cybersecurity, SaaS, digital media, healthcare IT, and fintech. Scopus leads rounds with initial checks up to $1 million, with capital reserved for follow-on investments across its two fund vehicles. Across approximately 30 investments, named portfolio companies include Torii (SaaS management platform, which later raised a $50 million round led by Tiger Global), Pienso (LLM fine-tuning with SRI International as a strategic investor), Aperio Systems (industrial cybersecurity, which raised a $9 million Series A), Fuel Cycle, Butler Hospitality, Phoneic, Perceptive AI, and Loops. The most recent disclosed investment is LawPro.ai — a priced seed round led by Scopus for AI tooling in the injury-claims market, closed in August 2025. Founders regularly describe Scopus as an operational partner rather than a passive financial investor. The firm emphasises hands-on support with positioning, hiring, and go-to-market strategy — capabilities that are particularly relevant for Israeli founders who are simultaneously building products and learning the commercial culture and sales dynamics of the US enterprise market.

SCOR Ventures is the corporate venture capital arm of SCOR, the French global reinsurer, founded in 2017 and headquartered in Paris with a globally distributed team of approximately six spanning London, New York, Chicago, Charlotte, and Singapore. The fund operates with a 130 million euro mandate and invests from seed through Series B, targeting 7.5 to 12.5 percent ownership at first check. Managing Partner Will Thorne (London) leads the team with SVP Kendall Crocker (New York) and a wider investment bench. The firm leads or co-leads roughly half of its deals. SCOR Ventures organises its thesis around three pillars: tech-driven underwriters and distributors (managing general agents and digital carriers), software solutions benefiting SCOR and its cedents, and companies helping people live healthier lives. Adjacent targets include fintech, digital health, climate technology, cybersecurity, financial operations software, industrial software, and employee benefits — sectors where SCOR's global risk network provides a meaningful distribution and validation edge. Geographic coverage spans North America, EMEA, and Latin America. Across 25 portfolio companies, named investments include Marshmallow (UK insurtech MGA), Protex AI (workplace safety computer vision), Kontempo (Latin America B2B buy-now-pay-later and trade finance), Novisto (ESG reporting software, invested May 2025), and Cartan Trade (trade-credit insurance, Series A in October 2025). SCOR's strategic value to portfolio companies goes beyond capital: the parent reinsurer's relationships with primary insurers, cedents, and risk carriers across more than 160 countries create natural commercial pathways for companies building in insurance-adjacent and risk-management technology verticals.

Scottish Equity Partners (SEP) is a prominent European growth equity investor that focuses on scaling fast-growing technology companies. Founded in 2000 and headquartered in Glasgow, Scotland, SEP has a strong presence in both the UK and internationally, with offices in London and strong connections across Europe and the US. SEP's portfolio includes notable companies like Skyscanner, which grew significantly under SEP’s investment, expanding from a small flight search business into a major global online travel brand before its acquisition by Trip.com for £1.5 billion in 2016. Another standout is Babbel, an online language learning app that became a market leader with over 10 million active subscribers, facilitated by SEP’s support in scaling internationally and strengthening its executive team. The firm typically invests in enterprise software and technology scaleups, with recent investments in companies such as Braincube, Cora Systems, and Pelion. SEP takes a hands-on approach, providing not only capital but also strategic guidance, leveraging their extensive network to help companies achieve sustainable growth. SEP’s team includes experienced partners like Calum Paterson and Stuart Paterson, who play active roles in their portfolio companies, ensuring that the companies have the necessary resources and guidance to succeed.

ScoutFund is a venture capital firm with a mission to mobilize human potential across all stages of life by investing in technologies that transform education and work. The firm leverages both philanthropic and investment capital to empower companies that are developing innovative solutions in these fields. ScoutFund focuses on startups that are poised to change the future, providing them with the necessary resources and support to scale their impact. In addition to direct investments, ScoutFund also collaborates with a network of partners and funds that share its mission, further amplifying its reach and effectiveness. The firm's portfolio includes a diverse array of companies that are pushing the boundaries in sectors like education technology, workforce development, and more. ScoutFund operates with a deep commitment to creating a positive impact, blending traditional venture capital strategies with a strong focus on social and educational innovation. ScoutFund's approach is designed to ensure that innovative ideas not only succeed commercially but also contribute meaningfully to society, making it a key player in the venture capital landscape focused on long-term, sustainable impact​.

Scout Ventures is a seed-stage venture capital firm based in Austin, Texas, focusing on dual-use technologies that have applications in both the private sector and government. Their investment areas include AI, machine learning, quantum computing, robotics, advanced materials science, security, space, and advanced energy. Notable portfolio companies include Taqtile, EnCharge AI, Tomahawk Robotics, DeepSig, and Assurely. These companies are working on innovative solutions ranging from AI-accelerated chips and robotic automation to targeted insurance products and sustainable agriculture technologies​. Scout Ventures typically leads seed rounds with investments ranging from $1 to $3 million and reserves capital to follow on through Series B. The firm’s team comprises mostly military service academy graduates with extensive experience in both government and the intelligence community, which provides them with unique insights and access to non-dilutive capital through defense and national lab networks​.

Scribble Ventures, founded in 2020 and based in Portola Valley, California, is an early-stage venture capital firm that focuses on pre-seed through Series A investments. The firm has a diverse portfolio spanning sectors like information technology, healthcare, software as a service, and consumer products. Notable investments include Whatnot, a platform for live video auctions, Synctera, which provides banking-as-a-service solutions, TrueNorth, a company focused on transforming trucker management, and WellTheory, which offers a membership-based approach to chronic care management. Scribble Ventures is led by Elizabeth Weil, who brings extensive experience from her tenure at OpenAI, Twitter, and Andreessen Horowitz. Scribble Ventures emphasizes a founder-first culture, providing not just capital but also strategic guidance and leveraging their extensive network to support portfolio companies. This support ranges from key introductions to aiding in product development and market strategies. The firm has made 130 investments to date and has seen several successful exits, including Run The World and Welcome.

Script Capital is a San Francisco-based venture capital firm specializing in early-stage investments in internet and software startups. Founded by AJ Solimine and Evan Tana, the firm focuses on partnering with technical founders at the pre-seed and seed stages, typically investing between $250,000 and $1 million per round​​. Their portfolio features a range of innovative companies, including Patreon, The Graph, Audius, and Sqreen. They have also invested in emerging companies like Lago, Doppel, and Orgnostic, which reflect their interest in web3, data, collaboration, and identity products​​. Script Capital's strategy emphasizes finding and supporting founders from the earliest stages of their journey, helping them navigate the challenges of achieving product-market fit. This hands-on approach is complemented by their Community Data project, which provides an open-data platform to assist founders in identifying and connecting with the right investors​​. The firm's recent $38 million pre-seed fund underscores its commitment to fostering early-stage innovation. This second fund has already demonstrated strong performance, with their inaugural fund marked up over five times and having distributed over 100% back to investors​.

Scrum Ventures is an early-stage venture capital firm founded in 2013, with headquarters in San Francisco and Tokyo. The firm has a robust portfolio of over 120 investments, focusing on sectors such as mobility, fintech, IoT, VR, commerce, and healthcare. Notable investments include companies like May Mobility, Kidaptive, and ExaWizards. The firm takes a thematic approach to investing, identifying emerging trends and supporting startups with capital, strategic advice, and access to a global network of corporate partners, particularly in Japan. Scrum Ventures has successfully leveraged its strong ties with Japanese corporations like Panasonic and Fujitsu to provide startups with opportunities for growth and innovation​. Led by founder Tak Miyata, Scrum Ventures emphasizes collaboration and co-innovation, offering startups not only financial backing but also direct assistance with hiring, fundraising, and market entry strategies. Their hands-on approach and extensive network make them a valuable partner for early-stage companies looking to scale globally. For startups, approaching Scrum Ventures with a clear value proposition and a strong potential for international expansion, particularly in the Japanese market, can be highly beneficial​.

SCVC is a Bristol-based early-stage venture capital firm that focuses on deep tech startups. It was co-founded in 2020 by Dr. Harry Destecroix and Jon Craton, both successful entrepreneurs with backgrounds in biotech and technology. SCVC is the venture arm of the Science Creates ecosystem, which supports innovative tech startups emerging from research institutions. The firm primarily invests in pre-seed and seed-stage startups, with typical investment sizes ranging from $500,000 to $3 million, and follow-on funding of up to $7 million for high-performing companies. SCVC is particularly focused on advanced technologies that improve human health and the environment, including biotech, quantum tech, AI, and semiconductors. Notable portfolio companies include VyperCore, a RISC-V processor company, Delta g, which develops quantum gravity sensors, and Scarlet Therapeutics, which pioneers red blood cell-based therapies. SCVC's mission is to support deep tech founders by offering not just capital but also hands-on expertise to turn their scientific breakthroughs into commercial ventures. With its second fund targeting $100 million, SCVC is expanding its efforts to back high-impact startups that are leading what they believe to be the next major industrial revolution​.

Seae Ventures is a Boston-based venture capital firm with a mission to advance equity in healthcare by investing in diverse entrepreneurs, particularly women and people of color. Founded in 2019 by former executives of Blue Cross Blue Shield of Massachusetts, Seae focuses on early-stage companies developing innovative healthcare technologies and services. Their $107 million inaugural fund is dedicated to startups addressing critical issues like mental health, women’s health, financial wellness, and personalized medicine. Notable investments include platforms like Health In Her Hue, which connects women of color to culturally competent healthcare providers, and Hurdle, a digital mental health service targeting underserved communities. Seae Ventures aims to create long-term value by balancing the needs of patients, providers, and payers while prioritizing companies that serve vulnerable populations. The fund is supported by a coalition of more than 30 investors, including major healthcare institutions like Blue Cross Blue Shield affiliates and Goldman Sachs. This strong backing allows Seae to provide not just capital, but also strategic support rooted in deep industry expertise. The firm’s founders, Jason Robart, Tuoyo Louis, and Pete Sally, leverage their vast experience in healthcare venture capital, corporate strategy, and human capital to guide their portfolio companies. Seae Ventures is committed to closing the gender and racial equity gaps in venture funding, making it a significant player in transforming the healthcare landscape for historically overlooked communities.

Seaside Ventures is an early-stage venture capital firm founded in 2021, operating between Santa Monica, California and Austin, Texas. The firm is co-led by founding partners Ryan Roddy and Harrison Valner, who together bring more than 20 years of combined operating and investing experience and have assembled a network of over 20 advisors and 30 strategic partners. Seaside's mission is focused on fueling the future of health and wellness — backing emerging technologies that improve health, boost happiness, and raise quality of life within the roughly $4 trillion global healthcare market. The firm's thesis targets startups that bridge scientific breakthroughs to real-world impact by addressing root causes of health challenges rather than symptoms. Seaside runs Fund I (a $10 million vehicle) alongside The Seaside Syndicate, which extends deal-by-deal access to aligned limited partners. Typical checks are in the low hundreds of thousands of dollars at pre-seed and seed. Across roughly 26 investments, named portfolio companies include ZBiotics (genetically engineered probiotics, $12 million Series A), StimScience (neuro-wellness, $10 million Seed in June 2025 led by Khosla Ventures), BiomeSense, Circulate, Adaptyx Biosciences, Calorify, and Rorra. The firm has produced two exits, the most recent being Aura Bora in February 2025. Seaside operates vertically across digital health, life sciences, food and beverage innovation, consumer wellness, supply-chain technology, and outdoor and active lifestyle — investing where rigorous science and genuine consumer demand overlap. Roddy and Valner approach each investment as a long-term partnership, working alongside founders on everything from early product validation to capital strategy and category positioning in health and wellness markets.

SeaX Ventures is a globally focused venture capital firm investing in early-stage companies working on "exponential" technologies that have the potential to transform industries and societies. With a strong emphasis on sectors such as Web3, biotechnology, artificial intelligence, material science, and robotics, SeaX Ventures actively supports visionary founders from around the world, helping them scale their groundbreaking innovations. The firm is known for its unique "3As" strategy: Access, Accelerate, and Advantage. Through their vast corporate network, which spans across Southeast Asia and the U.S., SeaX Ventures provides startups with valuable connections, leveraging the expertise of its sister company, RISE, which boasts over 2,000 startup alumni. SeaX Ventures has raised $60 million in its second fund and partners with large multinational corporations, especially from Southeast Asia, to bridge the gap between Silicon Valley and Asian markets. The firm's portfolio includes innovative companies such as Solana, Verdant Robotics, and Qvin, focusing on high-impact technologies. Their approach is to work closely with founders who are committed to transforming their industries, providing both strategic guidance and growth capital. Founded by experienced venture capitalists and entrepreneurs, SeaX Ventures is deeply involved in helping its portfolio companies reach their full potential by providing global market access and business development support. Their mission is to foster the next generation of transformative companies with a particular focus on deep tech that can drive significant economic and social progress.

Seaya Ventures is a leading venture capital firm with offices in Madrid and Mexico City, focusing on backing exceptional entrepreneurs in Europe and Latin America. Since its inception in 2013, Seaya has raised over €600 million across multiple funds, investing in early-stage technology companies that have global ambitions. The firm primarily targets sectors like fintech, climate tech, SaaS, and marketplaces, aiming to support startups that can scale internationally. Some of Seaya's most notable investments include Glovo, Cabify, and Wallbox, showcasing their commitment to high-growth sectors like mobility and green energy solutions. Seaya’s portfolio also includes Clarity AI, Clicars, and Pachama, indicating a strong focus on sustainability and impact-driven technology. Seaya's investment strategy revolves around partnering with founders to help them scale globally by providing strategic guidance, operational support, and access to an extensive network of investors and corporations. With its deep connections across Europe and Latin America, Seaya is uniquely positioned to help companies expand across these regions while leveraging its knowledge and expertise in global market trends. The firm’s newest initiative, Seaya Andromeda, focuses on climate-tech startups, marking its commitment to addressing global sustainability challenges through innovation.

Secocha Ventures, founded in 2013 and headquartered in Miami, Florida, is a dynamic venture capital firm with a strong track record in the FinTech, HealthTech, and Consumer Products & Services sectors. Their notable portfolio includes investments in companies like Brigit, Rebag, and Eaze, reflecting their commitment to supporting innovative, high-growth startups. Secocha Ventures primarily invests in Pre-Seed, Seed, and Series A stages, maintaining a geographically agnostic approach with investments in the USA, India, Israel, and France. Their investment strategy focuses on identifying disruptive companies and providing not just capital, but also mentorship and strategic guidance. They prefer B2C over B2B ventures, valuing persistence and transparency in their partnerships. The average check size varies, but they are known for leading rounds and being actively involved in the fundraising process. Secocha's team, led by founder Sanket Parekh and supported by key members like Bharath Thankavel and Tanai Kamat, brings a wealth of expertise and a hands-on approach to every investment. Startups seeking to engage with Secocha should be prepared to demonstrate clear market potential and a strong founding team. The firm values thoughtful introductions and prefers pitches that showcase strategic fit and potential for significant impact. With a collaborative and transparent approach, Secocha Ventures stands out as a vital partner for early-stage startups looking to disrupt the status quo and achieve scalable growth.

Section 32 is a venture capital firm founded by Bill Maris, the former CEO of Google Ventures. Established in 2017, the firm is based in San Diego, California, and manages approximately $1 billion in assets. Section 32 focuses on early and growth-stage investments across technology, biotechnology, healthcare, and life sciences sectors. The firm has raised multiple funds, including a $160 million inaugural fund and a $200 million second fund. Section 32's portfolio includes notable companies such as Coinbase, CrowdStrike, Thrive Earlier Detection, and Vir Biotechnology. The firm emphasizes investing in transformative technologies that can make a significant impact on the healthcare and tech industries. The team at Section 32 includes several seasoned professionals, such as Michael Pellini, former CEO of Foundation Medicine, who joined as a Managing Partner, and Steve Kafka, former President and COO of Foundation Medicine, who also serves as a Managing Partner. The firm prides itself on a strategic approach that combines deep industry expertise with a commitment to fostering innovation and growth in its portfolio companies.

Seed Capital, a premier venture capital firm based in Denmark, specializes in early-stage investments, particularly focusing on Danish startups or those with strong ties to Denmark. Established in 2004, Seed Capital has played a significant role in nurturing some of the most successful startups in the region. Their notable investments include Vivino, Lunar, Templafy, and Trustpilot, showcasing their broad sector expertise ranging from fintech to consumer internet and enterprise software. Seed Capital's investment strategy revolves around leading seed and Series A rounds with check sizes typically ranging from €2 million to €4 million, but they also maintain substantial reserves for follow-on investments to support companies through their growth stages. Seed Capital's approach is highly hands-on, providing portfolio companies with strategic support and access to a vast network of industry contacts. This includes operational assistance, business development, and guidance on subsequent funding rounds. The firm's commitment to long-term partnerships and deep engagement with founders has been a cornerstone of their success. The investment team, led by Managing Partners Lars Andersen and Ulla Brockenhuus-Schack, boasts a wealth of experience in scaling startups and driving value creation. With a gender-diverse team, Seed Capital emphasizes inclusive growth and leverages a collaborative approach to foster innovation within its portfolio.

Seedcamp is a leading early-stage venture capital firm in Europe, with a focus on backing ambitious founders building disruptive technology across various sectors. Founded in 2007, Seedcamp has a portfolio of over 460 companies, including high-profile successes like Revolut, UiPath, and Wise. Several of its investments have grown into unicorns, and two companies have gone public. The firm is sector-agnostic, investing in areas such as fintech, artificial intelligence, healthtech, and cybersecurity. Seedcamp typically invests early, providing first checks of up to $1 million in Angel and Seed rounds. Their approach combines the agility of an angel investor with the resources and operational support of a seasoned VC. Through their extensive network, including the Seedcamp Expert Collective (SxC), founders gain access to top operators from companies like Uber, Stripe, and Cloudflare, who offer guidance and mentorship to help startups scale quickly. Seedcamp is deeply embedded in Europe’s tech ecosystem, continually launching initiatives like Seedsummit to support early-stage founders with legal and operational advice. With their latest $180M Fund VI, they are well-positioned to lead the next decade of European tech growth​.

SeedIL Ventures is a boutique Israeli seed-stage venture capital firm headquartered in Herzliya. The platform began in 2014 as SeedIL Club, an accredited-angel syndicate of roughly 65 business angels, and was formalised into a dedicated fund in 2018 in a strategic partnership with Technion Drive — the Technion's innovation arm — giving the firm privileged access to deal flow from Israel's leading engineering university. SeedIL is co-founded and led by Managing Partners Audrey Chocron and Cynthia Phitoussi, both of whom also founded The Hive by Gvahim in 2010, one of Israel's earliest startup accelerators. The three-person investment team maintains a deliberately compact size to enable personalised, hands-on support for each portfolio founder. SeedIL's investment thesis covers seed-stage Israeli-related technology companies, explicitly excluding medtech and biotech. Fund II sharpens the focus to B2B in sectors where Israeli innovation has a proven edge: enterprise software, IT and cybersecurity, digital health, climate technology, agri and food tech, construction technology, and fintech. Initial checks range from $300,000 to $1 million. Across 31 to 34 investments, the firm has produced 7 exits — including Breezometer, Donde Search, Presenso, Smore, and most recently Dataloop in December 2025. Active portfolio names include Tolstoy (shoppable video commerce), xpander.ai (AI, co-invested with Samsung NEXT and Emerge Ventures), and Quack AI (the most recent disclosed investment, Seed-II in September 2025). SeedIL's model is built around deep founder relationships and intensive post-investment support: Chocron and Phitoussi work closely with each team on hiring, product positioning, international sales strategy, and access to follow-on investors, drawing on the networks they have built across more than a decade as ecosystem builders in the Israeli startup community.

SeedPlus is a Singapore-based early-stage venture capital firm that focuses on product-driven, deep-tech startups across Asia. Founded in 2016, the firm raised $18 million in its debut fund, backed by major players like Jungle Ventures, Cisco, and Eight Roads Ventures. SeedPlus targets innovative companies in sectors such as SaaS, fintech, AI, and e-commerce, aiming to support them from seed to Series A. The firm typically invests between $500K to $1 million per deal and plays a hands-on role in helping startups scale regionally and globally. Key portfolio companies include Homage, a caregiver marketplace, and EngageRocket, a SaaS platform focused on human resources analytics. SeedPlus is known for leveraging its extensive network of partners, such as Cisco, to provide startups with access to strategic resources, talent, and customers, giving them what they call an “unfair advantage” in the market. The team at SeedPlus, led by partners like Tiang Lim Foo, emphasizes the importance of investing in strong, execution-focused teams and targeting large, scalable markets. Their investment philosophy centers on building long-term relationships with founders, ensuring alignment on strategy and growth post-investment. This approach has led to significant exits and strong growth across their portfolio​.

SEEDRA Ventures is an early-stage venture capital firm based in Riyadh, Saudi Arabia, focused on fostering innovation and supporting disruptive technologies across various sectors in the region. Established with a mission to accelerate the growth of startups, SEEDRA provides both pre-seed and early-stage funding, helping entrepreneurs bring their ideas to life. The firm takes a hands-on approach, offering more than just capital. SEEDRA actively partners with its portfolio companies, providing technical expertise, mentorship, and access to an extensive network of industry professionals and strategic partners. Their focus spans multiple industries, including tech, retail, industrials, and financial services. SEEDRA Ventures also emphasizes scalability, offering guidance on building internal teams, navigating regulatory challenges, and developing go-to-market strategies. Their robust advisory network ensures that founders are well-supported as they tackle the challenges of growth. Moreover, the firm provides back-office support, recruitment services, and access to tools like AWS and Salesforce, which are critical for scaling startups. By focusing on cultivating the next generation of regional businesses, SEEDRA Ventures plays a vital role in driving the entrepreneurial ecosystem in Saudi Arabia, aligning with the broader goals of economic transformation under Vision 2030.

4Founders Capital is a Barcelona-based venture capital firm founded in 2017 by Jesús Monleón, Marc Badosa, Javier Pérez-Tenessa, and Marek Fodor. The firm focuses on early-stage investments, particularly in disruptive technology and internet-enabled businesses across Europe. They aim to support ambitious founders with an international mindset who are capable of creating large-scale companies exceeding €300 million in value. 4Founders Capital typically invests in pre-seed to Series A+ stages, with investment sizes ranging from €100,000 to €4 million. The firm prefers to take minority stakes and often co-invests with other experienced venture capital firms and business angels. Notable portfolio companies include Glovo, Holded, and Gamestry, highlighting their commitment to high-growth potential ventures. The team at 4Founders Capital brings extensive experience as serial entrepreneurs and investors, providing not only capital but also strategic guidance to help startups scale effectively. They leverage a robust network of co-investors and industry experts to add value to their portfolio companies. Recent investments reflect their focus on innovative sectors, with companies like TaxDown and Zerod (Network Management Software) being part of their portfolio. The firm remains active in the investment community, continually seeking opportunities to empower and partner with groundbreaking startups. For startups looking to engage with 4Founders Capital, demonstrating a strong technological foundation and scalable business model aligned with their investment criteria is essential​.

Seedstars Africa Ventures is an early-stage venture capital fund dedicated to backing high-growth technology companies across Sub-Saharan Africa. Operating from offices in Nairobi, Dakar, and Paris, the six-person team covers more than 25 SSA countries. The fund is co-led by Managing Partners Maxime Bouan and Tamim El Zein together with General Partner Bruce Nsereko-Lule, who is based full-time in Nairobi. Seedstars Africa Ventures I reached a first close of $42 million in December 2024, anchored by LBO France, and has secured approximately $50 million toward an $80 million final target. Limited partners include the African Development Bank ($10.5 million), the European Investment Bank's EIB Global vehicle ($30 million via the EU's ACP Trust Fund and Boost Africa), and additional institutional investors. The fund leads rounds and writes initial checks of $250,000 to $2 million into seed-plus and Series A companies, with meaningful follow-on capacity reserved. Sector approach is deliberately broad — fintech, payments infrastructure, agritech, energy access, education, healthcare, internet connectivity, and food systems — with a pronounced preference for companies addressing basic needs that reach large populations. Approximately $10 million has been deployed into five startups that together reach 60 million-plus people, connect 60,000 households to the internet, support 50,000 farmers, and deliver financial inclusion to 30,000 people across eight African countries. Named portfolio companies include Poa Internet (Kenyan ISP), Beacon Power Services (Nigerian grid-management SaaS), Shamba Pride (Kenyan agritech), and Bizao (pan-African payments). Seedstars Africa Ventures draws on the broader Seedstars Group's presence across 90-plus startup ecosystems worldwide, providing portfolio companies with connections to global investors, corporate partners, and peer networks that are otherwise difficult to access from Sub-Saharan Africa.

Seedstars International Ventures (SIV) is the flagship emerging-markets venture capital arm of the Seedstars Group, the Swiss-founded global platform operating 15 offices, 100-plus team members, and coverage of more than 90 startup ecosystems worldwide. SIV invests at pre-seed and seed stages across Latin America, Africa, MENA, Central and Eastern Europe, and Asia, with a deliberate focus on the economies projected to be among the top 20 by GDP in 2050: India, Indonesia, Brazil, Mexico, Nigeria, Egypt, Pakistan, the Philippines, and Vietnam. SIV Fund I was a $30 million vehicle; SIV Fund II (launched 2022) targets $30 million with a $20 million first close, backed by the IFC, Visa Foundation, the Rockefeller Foundation's Zero Gap Fund, and Symbiotics. Fund II is led by General Partner Patricia Sosrodjojo, a former Venture Partner at Indonesia's AC Ventures with 15-plus years of Asia-Pacific investing and consulting experience. Average checks run $150,000 to $350,000, and the fund leads rounds. The thesis centers on fintech and the future of commerce as multi-decade structural opportunities across emerging markets, with a strong preference for B2B models addressing access to financial services, healthcare, education, energy, agritech, e-commerce, and SaaS. Across 93-plus investments in 30-plus countries, named portfolio companies include Dastgyr (Pakistan B2B commerce), Foodics (MENA restaurant SaaS), OlaClick (Latin America), Omnibiz (Nigeria B2B commerce), and TAXO — where SIV led a $1.2 million seed alongside 500 Global. The portfolio has produced one unicorn (Webflow) and two acquisitions (Orcas and MyRobin). SIV's global network across the Seedstars platform gives its founders access to co-investor relationships, pilot partnerships, and market entry support in regions where early-stage capital and institutional ecosystem infrastructure remain thin relative to the scale of the opportunity.

SeedtoB Capital, headquartered in Atlanta, GA, is a venture capital firm focused on early-stage investments in the healthcare technology sector. Founded by serial entrepreneurs Ritesh Sharma and Shantanu Nigam, who previously co-founded Jvion—a leading clinical AI platform—SeedtoB is dedicated to supporting innovative startups that integrate advanced technology with clinical expertise. Their mission is to help these startups navigate the complex healthcare landscape and successfully transition from Seed to Series B funding. SeedtoB typically invests between $500,000 and $1.5 million in U.S.-based healthcare technology companies. They focus on startups that demonstrate early product-market fit, particularly those generating $500,000 or more in annual recurring revenue. The firm is especially interested in scalable business models that leverage AI to deliver significant clinical and community impact. SeedtoB is also committed to fostering diversity by actively seeking to invest in companies led by underrepresented founders. The firm's portfolio includes companies like Biotia, which uses AI and next-generation sequencing for rapid infectious disease detection, and Mployer Advisor, a platform transforming how employers evaluate and select insurance brokers. SeedtoB’s deep industry experience, particularly in healthcare AI, enables them to provide hands-on support to their portfolio companies, helping them overcome challenges and scale effectively. With a strong focus on innovation and impact, SeedtoB Capital is poised to drive significant advancements in healthcare technology, supporting entrepreneurs who are transforming the industry.

SEGNEL Ventures Pte Ltd is a Singapore-based seed and early-stage venture capital firm founded in 2015 by Hideki Fujita, who previously co-founded COENT Venture Partners. The firm operates as a small, concentrated vehicle focused on South Asia and Southeast Asia, with a particular emphasis on information technology and mobile-first startups at the seed through pre-Series A stage. Portfolio composition skews toward consumer technology, retail, enterprise applications, health technology, edtech, and media and entertainment, with the largest concentration in Malaysia and India, alongside Singapore, Indonesia, and the Philippines. SEGNEL has made 22 cumulative investments, with deal participation typically in the $1 million to $5 million range. Named portfolio companies include Parentune (Indian parenting platform), Adventoro (Malaysian travel experiences), Helpr (Southeast Asia on-demand services), and Pramp (educational and interview preparation software). The firm has produced 5 portfolio exits via acquisition, with Fave, POKKT, and FaveBiz among the most visible. The most recent disclosed acquisition was Favful, bought by iMEDIA in July 2021. Public investment records indicate that new-deal activity slowed materially after 2017 to 2018, suggesting the firm is now primarily managing and harvesting its existing portfolio rather than deploying new capital at pace. SEGNEL's value to its remaining active portfolio companies rests on Fujita's Southeast Asian operator networks and the firm's long-standing relationships across Malaysia, India, Singapore, Indonesia, and the Philippines — markets where his direct investing experience spans both the consumer internet wave of the 2010s and the mobile-first platforms that followed it.

Selva Ventures, founded in 2019, is an early-stage venture capital firm based in Los Angeles that specializes in health and wellness consumer brands. With a mission to make healthier living more accessible, affordable, and enjoyable, Selva Ventures invests primarily in seed and Series A startups with less than $10 million in sales. The firm has a strong emphasis on categories such as food and beverage, personal care, beauty, and wellness, with a growing interest in the beauty and personal care sectors due to their high margins and repeat purchase potential. Selva Ventures is known for its hands-on approach, providing not only capital but also strategic resources and emotional support to its portfolio companies. Notable investments include brands like MUD\WTR, a functional coffee alternative, and Surely, a non-alcoholic wine, both of which align with the firm’s focus on innovative products that resonate emotionally with consumers. The firm’s portfolio is also notable for its diversity, with over 50% of companies led by female or minority founders. Under the leadership of Kiva Dickinson, Selva Ventures uses a proprietary "5M" framework—focusing on Megatrend, Matter, Management, Momentum, and Market—to evaluate potential investments objectively. This approach has helped the firm establish strong relationships within the consumer goods community, including partnerships with industry giants like Unilever Ventures​.

SemperVirens Venture Capital is a Silicon Valley-based venture firm investing in startups that are transforming the worlds of health, wealth, and work. Founded in 2018, SemperVirens focuses on B2B technology companies, particularly those in health tech, fintech, and workforce tech sectors. Their unique approach is powered by the SemperSystem™, a proprietary operating system that leverages a vast network of investors, entrepreneurs, HR experts, and strategic partners. This system provides their portfolio companies with go-to-market deals, operational support, and deep market insights to accelerate growth. SemperVirens invests primarily in early-stage companies aiming to redefine how employers manage and support their workforce. Their portfolio includes innovative startups like Brightline and Spring Health in healthcare, Human Interest and Ladder in fintech, and workforce solutions like Fountain and Terminal. The firm’s network of over 1,500 HR leaders from Fortune 200 companies plays a critical role in scaling these startups, helping them gain traction in large enterprises. Led by co-founders Greg Golub, Robby Peters, and recently appointed CEO Stephan Roche, SemperVirens has built a reputation for its hands-on approach and commitment to creating a more human-centered economy. With over $225 million in assets under management and a portfolio of 60 companies, they are driving change in industries that impact millions of employees.

Sente Ventures is a Chicago-based global deep-tech investment platform founded in 2008 and led by Founder and CEO Serhat Cicekoglu. The firm invests across equity, debt, and hybrid vehicles in partnership with family offices and institutional limited partners, and operates with a team of 12 including 2 partners. The mission is to back zero-emission deep-tech solutions across human essentials — agriculture, food, and water — and the industrial circular economy: energy transition, logistics, and upcycling. Adjacent interests span supply-chain and warehouse technology, digital health, transportation, and industrial technology. Sente's positioning as a 'collective and collaborative' investor reflects its model of leveraging a diverse LP base, corporate partners, and non-dilutive debt capacity to help portfolio companies scale in capital-intensive, mission-critical sectors. The portfolio spans 56 startups across 24 countries with concentrations in the US, Turkey, Israel, and other emerging innovation hubs. Named investments include Kybele's Garden (biotech, pre-seed April 2024), AstraKode (blockchain development platform), and M-Based (seed, July 2024). The firm has produced one unicorn and three exits, most recently Udentify in October 2023. In 2025 Sente announced a framework agreement with DeepGreenX for a $25 billion, five-year Green Infrastructure Investment Program focused on clean energy generation, virtual grids, battery storage, microreactor power, and data center infrastructure supporting AI and compute hubs. Cicekoglu and the Sente team approach each investment as a long-term platform relationship rather than a transactional capital placement — combining capital structures, corporate development support, and international networks to accelerate the commercialisation of deep technology in sectors where patient, mission-aligned capital is rare.

Sentiero Ventures is a Dallas-based venture capital firm that focuses on early-stage investments in AI-enabled software companies. Founded by David Evans, Jon Eberly, and Kishore Khandavalli, the firm targets startups that are harnessing the power of artificial intelligence to drive transformative change in various industries. The firm's investment thesis is centered around "knowledge convergence," where human and machine intelligence work together to create innovative business solutions. Sentiero Ventures is particularly interested in B2B SaaS startups that are delivering AI-driven applications across six core areas: process automation, cognitive insights, cognitive engagement, data collection, AI tools, and generative AI. The fund looks for companies that have a fully developed product and have demonstrated some level of market viability through completed pilots or initial revenue. The firm’s geographic focus is primarily on U.S.-based companies, with a strong preference for those in Texas, although they are open to investments across North America. Sentiero Ventures typically invests in industries where its partners have direct experience, including business services, healthcare IT, financial services, and real estate. The firm aims to be a strategic partner, providing not just capital but also the extensive entrepreneurial and operational expertise of its founding team to help startups scale and succeed.

Sequel Venture Partners is a Boulder, Colorado-based early-stage technology venture capital firm founded in 1996 and headquartered at 4430 Arapahoe Avenue. The firm manages approximately $400 million in committed capital across its fund vintages and is run by a seven-person investment team including Founding Partners Tom Washing and Dan Mitchell, Managing Director Tim Connor, and William E. Mitchell. With nearly three decades of continuous operation, Sequel is one of the longest-tenured venture capital firms in the Rocky Mountain region. Sequel invests at seed through Series B in early-stage technology businesses across healthcare, enterprise IT, SaaS, clean technology, life sciences, manufacturing, digital health, the Internet of Things, and internet-based services. The firm leads rounds and has made 146 total investments with 37 portfolio exits across its history — a disciplined pace of roughly five new investments per year, reflecting a conviction-led model anchored by long partner tenure and deep Colorado ecosystem relationships. Recent activity includes a $1 million seed investment in Cognixion in June 2024 — a brain-computer-interface and biosignal-recognition platform for nonverbal users — led personally by Founding Partner Tom Washing. The most recent exit was Epicor in August 2024 (enterprise ERP and resource planning). Historical portfolio names include Aztek Networks and InfoNow, among many others across multiple fund vintages. Sequel's longevity and continuity of partnership are core to its founder proposition: the same partners who led investments in 1996 remain active and engaged in 2025, providing an unusual depth of pattern recognition across full technology cycles. The firm's Rocky Mountain orientation gives it a distinctive reach into Colorado and broader Intermountain West deal flow that coastal-focused funds routinely miss.

Seraph Group, founded in 2004 by Tuff Yen, is an angel investment firm based in Milton, Georgia, and Foster City, California. The firm focuses on early-stage technology startups, providing investments typically ranging from $50,000 to $1,000,000. Seraph Group operates through its Structured Angel Fund™ and Growth Equity Fund, offering diversified portfolios to its investors. Notable investments by Seraph Group include companies such as Lucira Health, known for its rapid test kits, Molecula, a data virtualization platform, and Second Genome, which focuses on microbiome research. The firm has made 168 investments and achieved 24 exits, highlighting its active role in the startup ecosystem. Seraph Group’s investment strategy involves a blend of financial support and strategic guidance, leveraging a network of over 390 investors. This network provides valuable insights and mentorship to the portfolio companies, facilitating their growth and development in the competitive market. The firm's approach emphasizes diversification and active engagement, ensuring that both investors and entrepreneurs benefit from their partnership.

Serena Capital, founded in 2008 and based in Paris, is a leading European venture capital firm focused on early-stage investments in innovative and ambitious technology companies. The firm has a diversified portfolio across sectors such as AI and data, fintech, healthtech, and consumer technology. Notable investments include iBanFirst, a fintech company providing international payment services; SanteVet, a leading pet health insurance provider; and Sequans Communications, a developer of semiconductor solutions for 4G and 5G networks. Serena Capital has also seen several successful exits, such as the acquisition of Evaneos by PSA Group and the public listing of Talend on the NASDAQ​ ​. The firm emphasizes active support for its portfolio companies through its extensive network and the Serena Squad, a community of C-level executives that offers mentorship and strategic guidance. Serena Capital aims to foster growth and innovation by partnering with entrepreneurs from the seed stage through series B​.

Serena Ventures, founded in 2014 by Serena Williams, is a venture capital firm that emphasizes investing in startups led by women and underrepresented founders. The firm, headquartered in Washington, D.C., has made over 96 investments across various sectors including fintech, e-commerce, health, and education technology. Notable investments include MasterClass, a streaming platform offering classes from industry leaders, and Tonal, a smart home gym company. Serena Ventures has also backed Impossible Foods, known for its plant-based meat substitutes, and Noom, a health app focused on behavior change for better wellness outcomes. The firm's portfolio highlights its commitment to diversity, with 53% of companies founded by women and 47% by Black founders. Serena Ventures recently raised $111 million to further support its mission, investing in startups such as Esusu, a fintech company helping renters build credit, and Parfait, an AI-powered wig customization platform. The firm continues to champion innovation and diversity in the startup ecosystem, leveraging Serena Williams' extensive network and influence to empower founders to change the world​.

Serra Ventures is a venture capital firm specializing in early-stage growth companies, with a particular emphasis on deep technology that addresses industry-specific problems. Founded to support innovation in the Midwest, the firm has since expanded its focus to include various regions across the U.S. and selected international markets. Serra Ventures has invested in over 100 companies, collaborating with more than 125 other venture capital firms. The firm primarily invests in sectors like AgTech and FoodTech, demonstrating a strong commitment to supporting companies that achieve product-market fit and exhibit strong revenue growth. Serra Ventures recently partnered with Grondex International to create the Serra-Grondex Ag & Food Tech Fund II, aimed at fostering regenerative solutions in the agriculture and food sectors. Serra Ventures is headquartered in Champaign, Illinois, with additional offices in San Diego, Chicago, and Park City. The managing partners, including Tim Hoerr, Dennis Beard, and Rob Schultz, bring extensive experience as former venture-backed CEOs, providing valuable insights and support to their portfolio companies.\

Service Provider Capital, founded in 2014 and based in Golden, Colorado, specializes in co-investing in seed and Series A deals led by institutional venture funds. The firm is known for making the investment process seamless by not negotiating terms or seeking board seats, and covering their own legal fees, ensuring a straightforward partnership for startups. Service Provider Capital has made over 462 investments across diverse sectors including artificial intelligence, machine learning, blockchain, cybersecurity, fintech, health, and more. Some of their notable exits include companies like Owlet Baby Care, BacklotCars, and Simplus. Their portfolio also features companies such as MagicSchool, Trace, and Backstitch, highlighting their involvement in educational software, business productivity tools, and media services. The firm’s approach involves leveraging their extensive LP and CEO networks to provide startups with potential investor connections, strategic partners, and customer introductions, thereby significantly enhancing the startups' reach and growth opportunities. This network-centric strategy aligns with their goal of supporting the success of their portfolio companies without imposing additional operational burdens. Key team members include co-founders Jody Shepherd and Noah Pittard, and Managing Directors Edward Hill and Galen Mason, who bring a wealth of experience and expertise to the firm. This leadership is instrumental in driving Service Provider Capital's mission to support and scale innovative startups across various industries.

Sesame Ventures is the corporate venture capital arm of Sesame Workshop, the New York-based non-profit media organization behind Sesame Street, with nearly five decades of child-development and curriculum expertise. Launched in 2016 under the oversight of Tanya Haider, Sesame Workshop's EVP of Strategy, Research, and Ventures, the fund partners with emerging companies innovating in education, health, and social welfare for children — applying Sesame Workshop's kid-centric design-thinking, research rigor, and whole-child pedagogy as value-add beyond capital. Sesame Ventures operates through Collab+Sesame, its flagship vehicle structured as a 50/50 partnership with Collaborative Fund, which serves as the General Partner. The initial fund raised $10 million (split equally between the two partners) and was subsequently scaled to approximately $15 million, backing a portfolio of 10 to 20 companies at seed and Series A with typical checks of $100,000 to $500,000. Sesame Ventures is also a limited partner in Reach Capital's edtech venture fund. Named portfolio investments include Luminopia (an FDA-approved digital therapeutic for pediatric amblyopia), Step (teen fintech and banking), Kano (creative computing for kids), Banjo Robinson (storytelling and edtech), and Yup Technologies (math tutoring), where Collab+Sesame led a $4 million seed extension. In January 2025 Sesame Ventures announced a strategic partnership with NewYork-Presbyterian Hospital, deepening the fund's focus on child health innovation. The fund's differentiated edge is access to Sesame Workshop's 50-year body of child-development research and its trusted brand with parents, educators, and policymakers — assets that financial VCs cannot replicate. Sesame Ventures pursues a double-bottom-line mandate: financial returns alongside measurable social impact for children.

Seven Peaks Ventures is an early-stage venture capital firm based in Bend, Oregon, and the signature regional VC partnering with technology founders across the Pacific Northwest and Western US. Founded in 2013 by Dino Vendetti — a 35-year venture and startup veteran with prior experience at Bay Partners, Vulcan Ventures, and Formative Ventures — the firm has grown to four General Partners, adding Tom Gonser (co-founder of DocuSign), Corey Schmid (former Philips executive), and Matt Abrams (former Oracle executive). Seven Peaks closed Fund II at $28 million to accelerate early-stage growth in regional startup hubs beyond Silicon Valley. The investment thesis spans capital-efficient technology businesses across enterprise software, digital health, AI and machine learning, IoT, robotics, cloud infrastructure, space technology, renewable energy, fintech, and cybersecurity. Seven Peaks leads rounds and deploys initial checks of $500,000 to $1 million, with follow-on capacity into portfolio companies as they scale. Across 65 investments the firm has produced 17 exits, including 1 IPO and 9 acquisitions. Notable portfolio outcomes include Vungle, Enlitic, Bright.md, and Virtuous, and most recently the exit of UBCO Bikes in July 2025. Seven Peaks plays a distinctive ecosystem-building role in Oregon's "Silicon Forest" tech scene, cultivating regional angel networks and syndicating with coastal VCs to bring growth capital into Pacific Northwest deals. The partners are known for hands-on founder engagement that reflects their combined decades of operating experience at companies large and small.

Seven Seven Six is an early-stage venture capital firm founded in 2020 by Alexis Ohanian, based in Jupiter, Florida. The firm focuses on investments across various sectors, including technology, fintech, and healthcare. With nearly $1 billion in assets under management, Seven Seven Six utilizes a unique operating system called Cerebro to enhance portfolio monitoring and support. The firm's notable investments include companies like Helium, a provider of hardware mining solutions for cryptocurrency; Ro, a digital health platform; and Yuga Labs, known for its marketplace for games and digital collectibles. Recent investments in 2024 include Elektra Health, a health tech company, and Interlune, an aerospace, maritime, and defense company​. Seven Seven Six has achieved several successful exits, such as Proof Holdings and Kairos, and supports a diverse range of innovative startups with the potential to become industry leaders.

Seventure Partners, established in 1997, is one of Europe's leading venture capital firms, managing over €1 billion in assets. The firm primarily invests in two main sectors: Life Sciences, with a focus on health tech, biotech, microbiome, and digital health, and Digital Technologies, concentrating on fintech and insurtech. Seventure’s investment strategy involves rigorous but collegial processes, emphasizing strong relationships with management teams. The firm typically invests from Seed to Series B stages, with investment sizes ranging from €1.5 million to €15 million per round, and up to €20 million per company. They are often the lead investor and actively support portfolio companies through board representation and strategic guidance​. Headquartered in Paris, Seventure has additional offices in Munich, London, Geneva, and Basel. The team, comprising over 25 employees including 15 investors, works closely with entrepreneurs to help them achieve leadership positions in their respective fields​​. Seventure is also a pioneer in microbiome investments, having launched the world’s first dedicated microbiome fund. Their Health for Life Capital™ funds support companies revolutionizing healthcare through research in nutrition, digital health, and foodtech.

SeventySix Capital is a leading venture capital firm that focuses on investing in sports technology, esports, and sports betting startups. Founded by Wayne Kimmel, SeventySix Capital aims to support innovative companies that are transforming the sports industry through technology and data. The firm provides not only capital but also strategic guidance and extensive industry connections to help entrepreneurs succeed. The firm has a diverse portfolio, including companies such as VSiN, Nerd Street, and ShotTracker, which are leaders in their respective fields. SeventySix Capital's investment approach is comprehensive, involving hands-on support in areas like business development, marketing, operations, and public relations​. SeventySix Capital also operates the Athlete Venture Group, which enables professional athletes to invest in and collaborate with startups. This initiative bridges the gap between athletes and the entrepreneurial ecosystem, offering athletes opportunities to leverage their capital and social influence in the tech sector. In addition to its venture investments, SeventySix Capital has launched the Sports Advisory venture, providing advisory services to sports executives, leagues, and organizations. This venture is led by industry veteran Dan Bravato and focuses on esports, sports betting, media, and social responsibility.

SFC Capital is a leader in early-stage investment in the UK, particularly known for its Seed Enterprise Investment Scheme (SEIS) and Enterprise Investment Scheme (EIS) funds. Established in 2012, SFC has developed a unique co-investment model that combines direct angel investments with diversified portfolio management. This approach enables investors to back innovative startups while benefiting from substantial tax relief under SEIS and EIS, making it particularly attractive to high-net-worth individuals. The fund focuses on sectors ranging from tech and SaaS to consumer goods, supporting a wide range of high-growth industries. SFC Capital typically invests in 15-20 companies per SEIS fund and has been recognized as one of the most active seed investors in Europe, with an impressive portfolio that includes over 100 investments. Their hands-on approach ensures that startups receive not only financial backing but also strategic support through mentoring and connections within the broader SFC network. The team is led by Stephen Page, an entrepreneur turned investor, with a strong supporting cast including COO Angelika Burawska and CIO Joseph Zipfel. They focus on early-stage companies, often from seed to pre-Series A, and are deeply integrated with the UK startup ecosystem, collaborating with Innovate UK and the British Business Bank. Startups looking for funding can expect rigorous due diligence, with SFC looking for clear market potential and strong leadership. They are open to a wide range of industries and encourage founders to reach out directly for investment opportunities.

SGH Capital, founded in 2014 and headquartered in Luxembourg, is a venture capital firm that invests in early and mid-stage disruptive technology companies across the US and Western Europe. With over 130 investments, SGH Capital has a strong track record of supporting innovative startups in various sectors, including fintech, healthcare, and enterprise software. Notable investments include Honey, acquired by PayPal in 2019; Bakkt, which went public in 2021; and Guardant Health, which had its IPO in 2018. Other significant portfolio companies are Carta, a platform for equity management, and Talkdesk, a customer service software provider. SGH Capital has also seen successful exits from companies like Onfleet, an advanced logistics platform, and Eight Sleep, a health and wellness tech company. SGH Capital is known for its hands-on approach, providing strategic guidance and leveraging a vast network to help portfolio companies scale and achieve significant milestones. The firm has contributed to the growth of more than 10 unicorns and has been involved in over five IPOs.